Mitchell W. Kitayama - 07 Nov 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Reporting relationship: Director
Issuer ticker: ASTH
Reported as of: 07 Nov 2025
Net transaction value: +$218,400
SEC form: 4
Accepted by SEC: 12 Nov 2025, 17:06:10 UTC
Prior SEC filing: 15 Sep 2025
Next SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathy Diep, as Attorney-in-Fact

Key filing fact

Mitchell W. Kitayama filed Form 4 for Astrana Health, Inc. (ASTH) on 12 Nov 2025.

Key facts

This page summarizes Mitchell W. Kitayama's Form 4 filing for Astrana Health, Inc. (ASTH).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Nov 2025, 17:06.

Change

Previous filing in this sequence was filed on 15 Sep 2025.
Current net transaction value: +$218,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001333154 Primary reporting owner

Kitayama Mitchell W

Relationship: Director
Address: C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVE, 2ND FLOOR, ALHAMBRA
Signature: /s/ Kathy Diep, as Attorney-in-Fact
Signature date: 12 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASTH transaction

Common Stock

Options Exercise

Transaction value: $218,400
Shares: +12,000
Change %: +76%
Price: $18.20
Shares after: 27,846
Date: 07 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASTH transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -12,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 07 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,000
Exercise price: $18.20
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

Footnote F2

These stock options were fully vested and exercisable.